AstraZeneca’s release Monday of encouraging data about its coronavirus vaccine from its U.S. trial raised hopes that the drug company could put a troubled rollout behind it. But just hours after its announcement, American officials issued an unusual statement expressing concern the company had included “outdated information” from its study and that it may have provided “an incomplete view of the efficacy data.”
Related posts
-
Suburban skaters mourn D.C. plane crash victims they’d just seen at Kansas competition
Some of the victims on the American Eagle flight that crashed into the Potomac River after... -
Suburban skaters mourn D.C. plane crash victims they’d just seen at Kansas competition
Some of the victims on the American Eagle flight that crashed into the Potomac River after... -
The MSL’s tradition should not be taken lightly
While the realignment plans for the Mid-Suburban League carry a noble goal, the loss of tradition...